STRUCTURED COMPARISON
Build a comparison
Choose two categories from the same family. The same properties, equal visual weight, sources next to the claims they support.
STRUCTURED COMPARISON
Choose two categories from the same family. The same properties, equal visual weight, sources next to the claims they support.
Tobacco & nicotine
Nicotine pouches are small, pre-portioned sachets placed under the lip that contain no tobacco leaf. Instead of tobacco, they use a base of plant fibers, cellulose or other fillers carrying nicotine, along with pH adjusters, sweeteners, flavorings and binders. The nicotine may be derived from tobacco and purified, or manufactured synthetically, depending on the product. Because there is no tobacco leaf and no combustion, the exposure profile differs from both smoking and traditional smokeless tobacco. Products vary widely in strength, flavor and formulation. This overview is neutral and distinguishes nicotine pouches by their tobacco-free composition; it does not imply that they are safe or that they are harmful.
Snus is a moist smokeless tobacco product traditionally used in Scandinavia. It is made from ground tobacco leaf combined with water, salt, humectants and flavorings, sold loose or in small portion sachets. Because it contains real tobacco, it delivers nicotine along with other compounds naturally present in tobacco. Users place it under the upper lip rather than smoking it, so there is no combustion. Composition, moisture and nicotine levels vary considerably between brands and markets. This description is neutral and does not imply that snus is safe or unsafe; it simply distinguishes snus by its tobacco-leaf base, which is the fundamental composition difference from tobacco-free products.
Oral nicotine pouches are a recently emerged class of tobacco products which, unlike conventional oral smokeless tobacco products, contain a nicotine powder instead of tobacco leaves. That is precisely the difference in kind from snus: there is no tobacco leaf in the product, while nicotine is present. The product remains a tobacco product in regulatory terms — a separate row covers that.
In modern oral nicotine products the measured quantities are harmful and potentially harmful constituents: tobacco-specific nitrosamines, carbonyls, benzo[a]pyrene, nitrite and metals. The comparison covered 21 products against four traditional tobacco products, so the list of what is measured is the same for both categories — what differs are the values obtained. This is a statement about what is measured, not about what follows for health: separate rows deal with that.
Nicotine pouches deliver nicotine that is either extracted from tobacco or made synthetically, held on a non-tobacco carrier. When placed under the lip, nicotine is absorbed through the oral mucosa, bypassing the lungs. Labeled strengths span a broad range, and some products advertise notably high nicotine content per pouch. Absorption depends on pH, moisture, formulation and how long the pouch is kept in place. Nicotine is addictive irrespective of whether it originates from tobacco or is synthetic. Because labeling standards and measurement methods differ by market, stated milligram figures are not always directly comparable between brands. This entry explains delivery only and offers no health guidance.
Oral nicotine pouches exist in a single form — a porous pouch containing a nicotine powder instead of tobacco leaf. There is no loose variant in this category, and it is the absence of the leaf, not the format, that separates it from snus.
Snus is sold in two forms — as fine-cut loose tobacco and in pre-portioned porous pouches. Both contain tobacco leaf; the choice between them is a matter of convenience rather than composition.
As nicotine pouches rest against the gum and lip, reported effects tend to be local. Users have described gum irritation, soreness, a burning or tingling sensation and occasional mucosal changes at the placement site. Because the category is relatively new, long-term data on oral tissue outcomes are limited, and much current information comes from short-term reports or manufacturer testing. Whether specific changes are transient or persistent is not yet well established. Strength, flavor additives and frequency of use may influence local response. This summary presents the available local-effect observations neutrally, noting that the evidence base is thin rather than concluding that pouches are gentle or harmful.
Nicotine pouches are used by placing a pre-portioned sachet under the upper or lower lip and leaving it there, commonly for roughly twenty minutes to an hour, before discarding it. No lighting, spitting or inhaling is required, and the pouches are typically sold in tins with a range of flavors and strengths. Usage patterns, such as pouches per day, vary between individuals. Because they produce no smoke or visible vapor and require no spitting, they are often used discreetly in various settings. Marketing frequently emphasizes flavor variety and convenience. This description characterizes how the product is typically used and does not endorse or discourage any pattern of consumption.
Regulation of nicotine pouches is evolving and inconsistent across countries. Because many contain no tobacco, they do not always fall under existing tobacco laws, leading some jurisdictions to regulate them as tobacco-related products, others as consumer goods, chemicals or novel products, and some to restrict or ban them outright. Age limits, nicotine caps, flavor rules and labeling requirements differ widely and are frequently updated. In some markets specific products have entered formal review pathways, while elsewhere legal status remains unsettled. Synthetic nicotine has at times occupied regulatory gray areas. Readers should check the current rules in their own jurisdiction, as this is an area of active legislative change.
Counted for this table only, not for the whole site.
United States
FDA
First-ever MRTP orders (2019, renewed 2024) let eight General Snus products claim lower risk of certain diseases vs. cigarettes.
Germany
BfR
BfR: nicotine uptake comparable to cigarettes, TSNAs in some pouches; classed as novel food, withdrawn over acute reference dose.
Sweden
Public Health Agency of Sweden
Swedish national survey statistics on prevalence of daily and occasional snus, nicotine pouch, e-cigarette and smoking use (2024).
New Zealand
Manatū Hauora — Ministry of Health
Ministry of Health page on the rules for vaping, herbal smoking and smokeless tobacco products under the Smokefree Act 1990.
Both products are placed under the lip and deliver nicotine without combustion; what separates them is the presence of tobacco leaf. The differences run along nicotine content and absorption, habitual pattern of use and regulatory status. Reports of local effects in the mouth exist for both categories, but their severity and their link to the product are contested. For nicotine pouches long-term data is scarce because they are recent to the market; for snus data exists, but the conclusions are disputed.
FREQUENTLY EXPLORED
Snus is sold as fine-cut loose tobacco or in pre-portioned porous pouches. Some products undergo tobacco pasteurisation during manufacturing — a process that removes or reduces nitrite-forming microbes and therefore lowers the tobacco-specific nitrosamine content of the finished product. This is a production step, not a property of the raw material: unpasteurised snus exists.
In snus the measured quantities are moisture, pH, nicotine content and tobacco-specific nitrosamines — exactly what was compared across 64 products from ten manufacturers. Nitrosamine content is tied to manufacturing: pasteurisation of the tobacco removes or reduces nitrite-forming microbes and lowers their amount. This is a list of what is measured, not an assessment of the product's merit.
The nicotine in snus comes from the tobacco leaf itself. When a portion sits under the lip, nicotine is released and absorbed through the oral mucosa into the bloodstream, avoiding the lungs. Absorption is generally slower than inhaled smoke but can still produce meaningful nicotine exposure. Nicotine strength differs widely across products, and factors such as pH, moisture and portion size influence how much is delivered. Nicotine is an addictive substance regardless of source. Labeling conventions and measured free-nicotine levels vary by country and brand, so stated strengths are not always directly comparable. This entry describes delivery mechanics only and makes no health recommendation.
Because snus is held in direct contact with the gum and inner lip, most locally reported effects occur at the placement site. Users and studies have described gum irritation, soreness, white mucosal patches (lesions) and gum recession where the portion rests. Some of these changes may lessen if placement is rotated or use stops, while others are studied for longer-term significance. The strength and consistency of evidence for specific oral outcomes remains debated among researchers. Individual susceptibility, product composition and frequency of use all appear to matter. This summary reports observed local effects neutrally and does not conclude that they are trivial or that snus is harmful overall.
Nicotine pouches are a comparatively recent product, so long-term health evidence is sparse and still developing. Independent research on cardiovascular, oral and other outcomes is limited, and much available information is short-term or derives from manufacturers. The absence of tobacco leaf and combustion changes the exposure profile relative to smoking and to traditional smokeless tobacco, but this does not establish that pouches are safe. Nicotine dependence remains a recognized concern, and high-strength products raise questions about exposure. Public-health authorities in different countries take differing stances amid the uncertainty. This summary flags the evidence base as limited and immature rather than concluding that nicotine pouches are beneficial or harmful.
Snus has been used long enough in some regions for observational research to accumulate, yet interpretations of that evidence remain contested. Studies have examined associations with oral, cardiovascular and other outcomes, and findings are sometimes mixed or difficult to generalize across populations and product types. Nicotine dependence is a recognized concern. The absence of combustion changes the exposure profile compared with smoking, but this does not establish that snus is safe. Confounding factors, differing formulations and study designs complicate firm conclusions. Public-health bodies in different countries reach different positions. This summary flags the evidence as mixed and incomplete rather than settling whether snus is beneficial or harmful.
Snus is used orally without lighting or inhaling. It comes in loose form, which users shape into a portion by hand, or in pre-made sachets of varying size. A portion is typically tucked under the upper lip and held there for a period ranging from several minutes to an hour, then discarded. Patterns of use, including how many portions per day and total daily duration, differ substantially among individuals and cultures. Some people use it throughout the day. Because there is no smoke, use is often possible in settings where smoking is restricted. This description characterizes typical usage patterns and is not an endorsement of any consumption behavior.
Regulatory treatment of snus varies markedly by jurisdiction. Sale is prohibited in much of the European Union, with Sweden holding a long-standing exemption, while other countries permit it under tobacco-control frameworks with taxation, labeling and age restrictions. In the United States, certain snus products have been reviewed through federal tobacco pathways, with authorizations and marketing conditions applying only to named products. Because it is legally classified as a tobacco product in most places, general tobacco rules such as health warnings often apply. Regulations change over time. Readers should verify the current status in their own country rather than assume a single global rule applies.
Evidence reviewed: September 3, 2026
Sources are reviewed by the CONTRAST editorial team. External links open in a new tab.